![Bimeda US launches Macrosyn™ (tulathromycin injection) 100mg, becoming the first available and launched FDA-approved brand alternative Draxxin® in the US. - Swineweb.com - Complete Swine News, Markets, Commentary, and Technical Info Bimeda US launches Macrosyn™ (tulathromycin injection) 100mg, becoming the first available and launched FDA-approved brand alternative Draxxin® in the US. - Swineweb.com - Complete Swine News, Markets, Commentary, and Technical Info](https://swineweb.com/wp-content/uploads/2021/02/1MAC_Macrosyn-scaled.jpg)
Bimeda US launches Macrosyn™ (tulathromycin injection) 100mg, becoming the first available and launched FDA-approved brand alternative Draxxin® in the US. - Swineweb.com - Complete Swine News, Markets, Commentary, and Technical Info
![Virbac announces the approval of its first pharmaceutical for Swine and Cattle in the U.S. and a collaboration with Pharmgate Virbac announces the approval of its first pharmaceutical for Swine and Cattle in the U.S. and a collaboration with Pharmgate](https://us.virbac.com/files/live/sites/virbac-usa/files/News/TULISSIN%2025_100ml_Packshot_WEB_600X600_face.png)
Virbac announces the approval of its first pharmaceutical for Swine and Cattle in the U.S. and a collaboration with Pharmgate
![citramox la: SeQuent Scientific launches Citramox LA injection in 10 European countries - The Economic Times citramox la: SeQuent Scientific launches Citramox LA injection in 10 European countries - The Economic Times](https://img.etimg.com/thumb/msid-79661859,width-1200,height-900,imgsize-789288,overlay-economictimes/photo.jpg)